EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Biomimetic Liposomes for G-Protein-Coupled Receptor 120 Exo/Endogenous Coactivation to Reprogram Lipid Metabolism in Obesity-Associated Osteoarthritis

Ming-Yang Li, Li-Min Wu, Ming-Jie Xu, Mei-Ling Shen, Jie-Hao Chen, Qin-Jie Wu, Rui Wang, Yi Zeng, Yuan-Gang Wu, Hai-Bo Si, Xiao-Ting Chen, Hang Li und 3 weitere

ACS Nano · 2025

DOI: 10.1021/acsnano.5c02515 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2025. Verfasst von Ming-Yang Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China. Hauptthemen laut MEDLINE: Obesity, Osteoarthritis, Lipid Metabolism, Receptors, G-Protein-Coupled. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: West China Hospital, Sichuan University, China Postdoctoral Science Foundation, Natural Science Foundation of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) associated with obesity is increasingly recognized as a distinct phenotype, driven by lipid metabolic imbalance and related inflammation. A particularly troublesome issue is that even after successfully correcting obesity, OA progression and lipid metabolic imbalance persist within the joint microenvironment, suggesting local lipid metabolism regulation as a potential treatment option. G-protein-coupled receptor 120 (GPR120), a primary receptor for long-chain fatty acids (including docosahexaenoic acid, DHA), has recently been found to play a pivotal role in regulating lipid homeostasis and suppressing inflammation. Here, we present ChD-FL/sgGPR, enabling dual endogenous-exogenous GPR120 activation. ChD-FL/sgGPR is a chondrocyte-biomimetic, fluorinated phenylboronic acid (FPBA)-modified ionizable liposome that codelivers DHA and a CRISPRa system comprising GPR120-specific sgRNA (single guide RNA) and dCas9-VPR mRNA (dead Cas9 fused to VP64-p65-Rta activator domain). Specifically, FPBA modification of liposomes enhances lysosomal escape and nuclear entry of RNA, while coextrusion with chondrocyte membranes facilitates cartilage-targeted delivery. In the coculture system of adipocytes and OA chondrocytes, ChD-FL/sgGPR significantly boosts chondrocytes GPR120 expression, facilitates lipid clearance via PPARγ signaling, and diminishes inflammatory mediators. In obese rat OA models, intra-articular injection of ChD-FL/sgGPR prolongs local retention, inhibits cartilage catabolism, and mitigates subchondral bone deterioration, collectively decelerating OA progression. By integrating CRISPR-mediated gene upregulation with DHA-induced receptor stimulation, this platform rebalances lipid metabolism in OA cartilage, offering a promising, mechanism-driven therapy for obesity-associated OA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityOsteoarthritisLipid MetabolismReceptors, G-Protein-CoupledLiposomesBiomimetic MaterialsAnimalsHumansMiceMaleChondrocytes

Stichwörter der Autor:innen

gene deliverylipid metabolismliposomesmRNAobesityosteoarthritis

Substanzen

Receptors, G-Protein-CoupledLiposomes

Autor:innen und Institutionen

  • Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
  • Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
  • Core Facilities, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
  • Animal Laboratory Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
  • Stem Cell and Tissue Engineering Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.

ORCID-Profile: Hui-Qi Xie, Bin Shen

Förderung

  • West China Hospital, Sichuan University
  • China Postdoctoral Science Foundation
  • Natural Science Foundation of Sichuan Province
  • Science and Technology Department of Sichuan Province
  • National Natural Science Foundation of China

Zitieren

APA

Li, M. Y., Wu, L. M., Xu, M. J., Shen, M. L., Chen, J. H., Wu, Q. J., Wang, R., Zeng, Y., Wu, Y. G., Si, H. B., Chen, X. T., Li, H., Gong, C. Y., Xie, H. Q., & Shen, B. (2025). Biomimetic Liposomes for G-Protein-Coupled Receptor 120 Exo/Endogenous Coactivation to Reprogram Lipid Metabolism in Obesity-Associated Osteoarthritis. ACS Nano. https://doi.org/10.1021/acsnano.5c02515

Vancouver

Li MY, Wu LM, Xu MJ, Shen ML, Chen JH, Wu QJ, et al. Biomimetic Liposomes for G-Protein-Coupled Receptor 120 Exo/Endogenous Coactivation to Reprogram Lipid Metabolism in Obesity-Associated Osteoarthritis. ACS Nano. 2025. doi:10.1021/acsnano.5c02515

BibTeX
@article{Li2025,
  author = {Li, Ming-Yang and Wu, Li-Min and Xu, Ming-Jie and Shen, Mei-Ling and Chen, Jie-Hao and Wu, Qin-Jie and Wang, Rui and Zeng, Yi and Wu, Yuan-Gang and Si, Hai-Bo and Chen, Xiao-Ting and Li, Hang and Gong, Chang-Yang and Xie, Hui-Qi and Shen, Bin},
  title = {Biomimetic Liposomes for G-Protein-Coupled Receptor 120 Exo/Endogenous Coactivation to Reprogram Lipid Metabolism in Obesity-Associated Osteoarthritis},
  journal = {ACS Nano},
  year = {2025},
  doi = {10.1021/acsnano.5c02515}
}
Kostenlos starten →